Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17441
-
17442
-
17443
-
17444
-
17445
-
17446
-
17447
-
17448
-
17449
Table1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppress...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17450
DataSheet3_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17451
DataSheet4_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17452
DataSheet1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17453
DataSheet6_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17454
DataSheet5_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17455
DataSheet2_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17456
DataSheet7_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp...
Published 2021“…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
-
17457
<i>Sox2</i> and <i>Fgf20</i> interact during cochlea development—quantitative analysis.
Published 2019“…(B-E) Quantification of (B) cochlear duct length, (C) total inner hair cells (IHCs) and IHCs per 100 μm of the cochlear duct, (D) total outer hair cells (OHCs) and OHCs per 100 μm, and (E) total supporting cells (SCs) and SCs per 100 μm at P0 in <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup>, <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, and <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup> cochleae. Error bars, mean ± SD. n = (B) 5, 6, 5, 6, 6, 6, 4, 10, 10; (C, D) 5, 5, 5, 4, 4, 4, 4, 5, 6; (E) 4, 5, 3, 3, 3, 3, 3, 5, 5. …”
-
17458
VR Study: Relevant Data
Published 2024“…We sought to explore the predictors of the social experience of virtual reality presentations of a Western art music concert.</p> <p>We used a pragmatic, mixed methods approach to collect the data. 50 participants were presented a monoscopic 360° VR recording of a string quintet concert. …”
-
17459
Open question responses VR
Published 2024“…We sought to explore the predictors of the social experience of virtual reality presentations of a Western art music concert.</p> <p>We used a pragmatic, mixed methods approach to collect the data. 50 participants were presented a monoscopic 360° VR recording of a string quintet concert. …”
-
17460